alovudine has been researched along with Hematologic Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayouth, JE; Bhatia, SK; Buatti, JM; Graham, MM; Gross, BA; Jacobson, GM; McGuire, SM; Menda, Y; Ponto, LL; Smith, BJ; Sun, W; Sunderland, JJ | 1 |
| Buck, AK; Fayad, L; Graham, MM; Herrmann, K; Juweid, ME; Menda, Y; Tewson, T; Thomas, D | 1 |
| Agool, A; Jager, PL; Schot, BW; Vellenga, E | 1 |
1 trial(s) available for alovudine and Hematologic Diseases
| Article | Year |
|---|---|
Using [(18)F]Fluorothymidine Imaged With Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity Due to Chemoradiation Therapy for Pelvic Cancer Patients.
Topics: Adult; Aged; Chemoradiotherapy; Dideoxynucleosides; Female; Hematologic Diseases; Humans; Male; Middle Aged; Pelvic Neoplasms; Positron-Emission Tomography; Radiation Injuries; Radiation Protection; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Reproducibility of Results; Sensitivity and Specificity | 2016 |
2 other study(ies) available for alovudine and Hematologic Diseases
| Article | Year |
|---|---|
PET/CT with 18F-FLT is unlikely to cause significant hepatorenal or hematologic toxicity.
Topics: Dideoxynucleosides; Head and Neck Neoplasms; Hematologic Diseases; Humans; Kidney Diseases; Liver Diseases; Lymphoma; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Tomography, Emission-Computed | 2010 |
18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment.
Topics: Aged; Bone Marrow; Dideoxynucleosides; Female; Fluorine Radioisotopes; Hematologic Diseases; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2006 |